The prevalence of diabetic kidney disease has increased in line with the increasing prevalence of diabetes, despite the use of agents that lower plasma glucose levels and inhibit the renin-angiotensin-aldosterone system (RAAS), suggesting that other pathways may also impact on the development of this condition (de Boer et al., 2011). The gene discussed is REN; the disease is diabetic kidney disease.